|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$59,537.25 |
2.87% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$51,104.43 |
2.47% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$46,798.88 |
2.26% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,515.70 |
2.25% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,011.33 |
2.22% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$45,848.52 |
2.21% |
| Waters Corporation |
WAT |
941848103 |
120 |
$45,528.00 |
2.20% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$44,154.49 |
2.13% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,981.96 |
2.12% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,674.35 |
2.11% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,671.29 |
2.11% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$43,470.21 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$43,578.37 |
2.10% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,495.48 |
2.10% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$42,871.44 |
2.07% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$42,894.72 |
2.07% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$42,924.42 |
2.07% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$42,970.45 |
2.07% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$42,850.71 |
2.07% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$42,252.90 |
2.04% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$41,962.10 |
2.03% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$42,051.79 |
2.03% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$41,811.14 |
2.02% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$41,913.96 |
2.02% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$41,705.66 |
2.01% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$41,709.12 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,310.56 |
1.99% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$41,223.88 |
1.99% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,013.70 |
1.98% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$41,110.30 |
1.98% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$39,924.94 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,073.66 |
1.93% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$39,726.72 |
1.92% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,481.98 |
1.91% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$39,307.59 |
1.90% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$38,542.91 |
1.86% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,196.34 |
1.84% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$37,852.11 |
1.83% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$37,790.90 |
1.82% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,693.31 |
1.82% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,510.90 |
1.81% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$37,527.60 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,210.02 |
1.80% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$36,974.23 |
1.79% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$37,163.74 |
1.79% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$35,935.62 |
1.74% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$35,738.00 |
1.73% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$35,532.72 |
1.72% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$33,559.99 |
1.62% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,751.08 |
1.58% |
| US Dollar |
$USD |
|
2,092 |
$2,091.88 |
0.10% |
| Japanese Yen |
$JPY |
|
102,506 |
$663.34 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|